FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Links shared publicly online about this topic.
- 875total visits
FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Faslodex (fulvestrant) is used to treat metastatic breast cancer. Includes Faslodex side effects, interactions and indications.
View full resource at drugs.com
Tags: Cancer, Breast Cancer, Metastatic Breast Cancer, Women's Health, FDA
Most Recently Shared on September 14, 2010 at 12:58 am By:
FDA Approves New Dosing for Faslodex in Treatment of Metastatic Breast Cancer - http://bit.ly/8ZB720
Advertisement
